UBS AM’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,620
| Closed | -$492K | – | 2902 |
|
|
2024
Q1 | $492K | Buy |
11,620
+5,130
| +79% | +$217K | ﹤0.01% | 2291 |
|
|
2023
Q4 | $271K | Buy |
6,490
+996
| +18% | +$41.6K | ﹤0.01% | 2441 |
|
|
2023
Q3 | $207K | Buy |
+5,494
| New | +$207K | ﹤0.01% | 2514 |
|
|
2022
Q1 | – | Sell |
-8,483
| Closed | -$425K | – | 2833 |
|
|
2021
Q4 | $425K | Sell |
8,483
-549
| -6% | -$27.5K | ﹤0.01% | 2611 |
|
|
2021
Q3 | $575K | Buy |
9,032
+6,241
| +224% | +$397K | ﹤0.01% | 2443 |
|
|
2021
Q2 | $201K | Sell |
2,791
-2,159
| -44% | -$155K | ﹤0.01% | 2710 |
|
|
2021
Q1 | $365K | Buy |
4,950
+953
| +24% | +$70.3K | ﹤0.01% | 2462 |
|
|
2020
Q4 | $293K | Buy |
+3,997
| New | +$293K | ﹤0.01% | 2417 |
|
|
2017
Q4 | – | Sell |
-19,330
| Closed | -$2.18M | – | 2610 |
|
|
2017
Q3 | $2.18M | Buy |
19,330
+34
| +0.2% | +$3.83K | ﹤0.01% | 1369 |
|
|
2017
Q2 | $2.16M | Buy |
19,296
+39
| +0.2% | +$4.37K | ﹤0.01% | 1335 |
|
|
2017
Q1 | $2.25M | Buy |
19,257
+4,922
| +34% | +$574K | ﹤0.01% | 1303 |
|
|
2016
Q4 | $1.51M | Sell |
14,335
-5,384
| -27% | -$567K | ﹤0.01% | 1405 |
|
|
2016
Q3 | $2.18M | Buy |
19,719
+5,445
| +38% | +$602K | ﹤0.01% | 1344 |
|
|
2016
Q2 | $2.08M | Buy |
14,274
+11,053
| +343% | +$1.61M | ﹤0.01% | 1348 |
|
|
2016
Q1 | $461K | Buy |
3,221
+100
| +3% | +$14.3K | ﹤0.01% | 1972 |
|
|
2015
Q4 | $482K | Buy |
+3,121
| New | +$482K | ﹤0.01% | 2077 |
|